Vera et al. [11] demonstrated that NGF/TrkA could promote the malignant behavior of ovarian cancer cells by upregulating oncogenic proteins such as vascular endothelial growth factor and c-myc expression during ovarian cancer progression. This evidence concerns the gene NTRK1 and ovarian carcinoma.